生存期超过3年卵巢癌患者临床特征及预后影响因素分析

Clinical characteristics of varian cancer patients with survival time over 3 years and its influencing factors of prognosis

  • 摘要:
      目的  探讨生存期超过3年的卵巢癌患者的临床特征及其预后相关影响因素。
      方法  回顾性分析87例卵巢癌患者的病例资料,探讨患者的临床特征及影响预后的相关影响因素。
      结果  87例卵巢癌患者的平均年龄为(52.58±10.23)岁,按照生存时间分为生存时间>3年组及生存时间≤3年组。生存时间>3年组共54例,其中17例死亡,存活37例; 生存时间≤3年组共33例,其中22例死亡,存活11例。同时剔除了生存期≤3年仍然存活者11例,共76例患者纳入后续研究。通过Kaplan-Meier法及Cox多因素对预后影响因素进行分析,结果表明手术、临床分期、初诊卡氏功能状态评分(KPS评分)、化疗周期、中药使用时间是影响卵巢癌患者预后的独立因素。
      结论  早期诊断,彻底的手术治疗,规范、足量及多疗程的化疗,合理配合中医药治疗,是提高卵巢癌患者生存率的关键。

     

    Abstract:
      Objective  To explore the clinical characteristics of varian cancer patients with survival time over 3 years with and its influencing factors of prognosis.
      Methods  The clinical data of 87 patients with ovarian malignancy were analyzed retrospectively, and the clinical characteristics and its influencing factors of prognosis were observed.
      Results  The average age of 87 patients with ovarian cancer was (52.58±10.23) years old. According to the survival time, they were divided into the survival time >3 years group (n=54) including 17 deaths and 37 survival patients and the survival time ≤3 years group (n=33) including 22 deaths and 11 survival patients. At last, a total of 76 patients were included in the study except for 11 survival patients with survival time ≤3 years. Kaplan-Meier survival analysis and Cox multiple factor survival analysis showed that operation, clinical staging, Karnofsky function and status(KPS) scores, cycles of chemotherapy, the use of traditional Chinese medicine were the prognostic factors of patients with ovarian cancer.
      Conclusion  Early diagnosis, operation treatment thoroughly, specification, sufficient and multiple courses of chemotherapy, combined with traditional Chinese medicinal treatment can prolong the survival time of patients with ovarian cancer.

     

/

返回文章
返回